Iatrogenic angioedema: Clinical features;Angio-œdèmes iatrogènes: particularités cliniques

Revue de Medecine Interne

Volumn 27, Issue SUPPL. 2, 2006, Pages

  Beaudouin, E ^a,b   Morisset, M ^a   Kanny, G ^a   Moneret Vautrin, D A ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b centre hospitalier Jean Monnet   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALLERGY; ANGIONEUROTIC EDEMA; ARTICLE; DISEASE PREDISPOSITION; ENZYME INHIBITION; HUMAN; HYPERKALEMIA; HYPOTENSION; IATROGENIC DISEASE; KIDNEY FAILURE; PATHOPHYSIOLOGY; RASH; RECURRENT DISEASE; URTICARIA; CHEMICALLY INDUCED DISORDER; DRUG THERAPY; REVIEW;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY; HUMANS; IATROGENIC DISEASE;

EID: 33748657596     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.03.011     Document Type: Article

References (29)

1. Pecquet C. Œdème de Quincke. Ann. Dermatol. Venereol. 130 (2003) 219-224
2. Kaplan A.P., and Greaves M.W. Angio-oedema. J. Am. Acad. Dermatol. 53 (2005) 373-388
3. Morimoto T., Gandhi T.K., Fiskio J.M., Seger A.C., So J.W., Cook E.F., et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J. Eval. Clin. Prat. 10 (2004) 499-509
4. Jett G.K. Captopril-induced angio-oedema. Ann. Emerg. Med. 13 (1984) 489-490
5. Pillans P.I., Coulter D.M., and Blak P. Angio-oedema and urticaria with angiotensin converting enzyme inhibitors. Eur. J. Clin. Pharmacol. 51 (1996) 123-126
6. Ducroix J.P., Outurquin S., Benabes-Jezraoui B., Gras V., Chaby G., Strunski V., et al. Angio-œdèmes et inhibiteurs de l'enzyme de conversion de l'angiotensine : à propos de 19 cas. Rev. Med. Int. 25 (2004) 501-506
7. Cicardi M., Zingale L.C., Bergamaschini L., and Agostini A. Angio-oedema associated with angiotensin-converting enzyme inhibitor use. Outcome after switching to a different treatement. Arch. Intern. Med. 164 (2004) 910-913
8. Kostis J.B., Kim H.J., Rusnak J., Casale T., Kaplan A., Corren J., et al. Incidence and characteristics of angio-oedema associated with enalapril. Arch. Intern. Med. 165 (2005) 1637-1642
9. Agostini A., Cicardi M., Cugno M., Zingale L.C., Gioffré D., and Nussberger J. Angio-oedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology 44 (1999) 21-25
10. Agah R., Bandi V., and Guntupalli K.K. Angio-oedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med. 23 (1997) 793-796
11. Messerli H.F., and Nussberger J. Vasopeptidase inhibition and angio-oedema. Lancet 356 (2000) 608-609
12. Sabroe R.A., and Black A.K. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br. J. Dermatol. 136 (1997) 153-158
13. O'Ryan F., Poor D.B., and Hattori M. Intraoperative angio-oedema induced by angiotensin-converting enzyme inhibitors: overview and case report. J. Oral Maxillofac. Surg. 63 (2005) 551-556
14. Oudit G., Girgrath N., and Allard J. ACE inhibitor-induced angio-oedema of intestine: case report, incidence, physiopathology, diagnosis and management. Can. J. Gastoenterol. 15 (2001) 827-832
15. Schmidt T.D., and McGrah K.M. Angiotensin-conveting enzyme inhibitor angio-oedema of intestine: a case report and review of the literature. Am. J. Med. Sci. 324 (2002) 106-108
16. Molinaro G., Cugno M., Perez M., Lepage Y., Gervais N., Agostini A., et al. Angiotensin-converting enzyme inhibitor-associated angio-oedema is characterized by a slower degradation of des-arginine9-bradykinin. J. Pharma. Exp. Ther. 303 (2002) 232-237
17. Adam A., Cugno M., Molinaro G., Perez M., Lepage Y., and Agostini A. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet 359 (2002) 2088-2089
18. Acker C.G., and Greenberger A. Angio-oedema induced by the angiotensin II blocker losartan. N. Engl. J. Med. 333 (1995) 1572
19. Van Rijinsoever E.W., Kwee-Zuiderwijk W.J.M., and Feenstra J. Angiotensin oedema attributed to use of losartan. Arch. Intern. Med. 158 (1998) 2063-2065
20. Cha Y.J., and Pearson V.E. Angio-oedema due to losartan. Ann. Pharmacother. 33 (1999) 936-938
21. Warner K.K., Visconti J.A., and Tschampel M.M. Angiotensin II receptor blockers in patients with ACE inhitor-induced angio-oedema. Ann. Pharmacother. 34 (2000) 526-528
22. Abdi R., Dong V.M., Lee C.J., and Ntoso K.A. Angiotensin II receptor blocker-associated angio-oedema: on the heels of ACE inhitor angio-oedema. Pharmacotherapy 22 (2002) 1173-1175
23. Fuschs S.A., Meyboom R.H.B., Van Puijenbroek E.P., and Guchelaar H.J. Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angio-oedema. Pharm. World Sci. 26 (2004) 191-192
24. Campbell D.J., Krum H., and Esler M.D. Losartan increases bradykinin levels in hypertensive humans. Circulation 111 (2005) 315-320
25. Halleberg P., and Brenning G. Angio-oedema induced by tramadol - a potentially life-theatening condition. Eur. J. Clin. Pharmacol. 60 (2005) 901-903
26. Fraunfelder F.W., Solomon J., Druker B.J., Esmaeli B., and Kuyl J. Ocular side-effects associated with imatinib (Gleevec). J. Ocul. Pharmacol. Ther. 19 (2003) 371-375
27. Maalouf T., Angioï K., Champigneulle J., Guerci A., and George J.L. Œdème palprébral secondaire au traitement par inhibiteur de la tyrosine kinase : Glivec. À propos d'une observation anatomoclinique. J. Fr. Ophtalmol. 27 (2004) 107-109
28. Fuchs U., Zittermann A., Berthold H.K., Tenderich G., Deyerling K.W., Minami K., et al. Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angio-oedema. Transplantation 79 (2005) 981-983
29. Mahé E., Morelon E., Lechaton S., Sang K.H., Mansouri R., Ducasse M.F., et al. Cutaneous adverse events in renal transplantation recipients receiving sirolimus-based therapy. Transplantation 79 (2005) 476-482